NCT04593771View on ClinicalTrials.gov

Phase I Clinical Protocol of BCG-PPD in Healthy People

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

May 24, 2021

Study Completion Date

May 24, 2021

Conditions
Tuberculosis
Interventions
DRUG

BCG-PPD

BCG-PPD was used for skin test in 40 healthy people, and BCG-PPD was marketed in other 40 healthy people (as control)

Trial Locations (1)

610041

Sichuan Center for Disease Control and Prevention, Chengdu

All Listed Sponsors
collaborator

Sichuan Center for Disease Control and Prevention

OTHER_GOV

collaborator

Neijiang Center for Disease Control and Prevention

UNKNOWN

collaborator

Beijing Kangterike Statistical Technology Co., Ltd.

UNKNOWN

lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT04593771 - Phase I Clinical Protocol of BCG-PPD in Healthy People | Biotech Hunter | Biotech Hunter